Suppr超能文献

补体控制蛋白因子 H:好的、坏的和不足的。

Complement control protein factor H: the good, the bad, and the inadequate.

机构信息

Department of Medical Microbiology and Immunology, College of Medicine, University of Toledo, Toledo, OH 43614, United States.

出版信息

Mol Immunol. 2010 Aug;47(13):2187-97. doi: 10.1016/j.molimm.2010.05.007.

Abstract

The complement system is an essential component of the innate immune system that participates in elimination of pathogens and altered host cells and comprises an essential link between the innate and adaptive immune system. Soluble and membrane-bound complement regulators protect cells and tissues from unintended complement-mediated injury. Complement factor H is a soluble complement regulator essential for controlling the alternative pathway in blood and on cell surfaces. Normal recognition of self-cell markers (i.e. polyanions) and C3b/C3d fragments is necessary for factor H function. Inadequate recognition of host cell surfaces by factor H due to mutations and polymorphisms have been associated with complement-mediated tissue damage and disease. On the other hand, unwanted recognition of pathogens and altered self-cells (i.e. cancer) by factor H is used as an immune evasion strategy. This review will focus on the current knowledge related to these versatile recognition properties of factor H.

摘要

补体系统是先天免疫系统的重要组成部分,参与清除病原体和宿主细胞的改变,是先天免疫系统和适应性免疫系统之间的重要联系。可溶性和膜结合的补体调节剂可保护细胞和组织免受意外的补体介导的损伤。补体因子 H 是一种可溶性补体调节剂,对控制血液和细胞表面的替代途径至关重要。正常识别自身细胞标志物(即多阴离子)和 C3b/C3d 片段是因子 H 功能所必需的。由于突变和多态性,因子 H 对宿主细胞表面的识别不足与补体介导的组织损伤和疾病有关。另一方面,因子 H 对病原体和改变的自身细胞(即癌症)的不必要识别被用作免疫逃避策略。这篇综述将重点介绍与因子 H 这些多功能识别特性相关的最新知识。

相似文献

1
Complement control protein factor H: the good, the bad, and the inadequate.
Mol Immunol. 2010 Aug;47(13):2187-97. doi: 10.1016/j.molimm.2010.05.007.
2
Dual interaction of factor H with C3d and glycosaminoglycans in host-nonhost discrimination by complement.
Proc Natl Acad Sci U S A. 2011 Feb 15;108(7):2897-902. doi: 10.1073/pnas.1017087108. Epub 2011 Feb 1.
3
Staphylococcal Ecb protein and host complement regulator factor H enhance functions of each other in bacterial immune evasion.
J Immunol. 2013 Aug 15;191(4):1775-84. doi: 10.4049/jimmunol.1300638. Epub 2013 Jul 17.
5
Characterization of Binding Properties of Individual Functional Sites of Human Complement Factor H.
Front Immunol. 2020 Aug 4;11:1728. doi: 10.3389/fimmu.2020.01728. eCollection 2020.
6
Hijacking Factor H for Complement Immune Evasion.
Front Immunol. 2021 Feb 25;12:602277. doi: 10.3389/fimmu.2021.602277. eCollection 2021.
7
Quantification of Factor H Mediated Self vs. Non-self Discrimination by Mathematical Modeling.
Front Immunol. 2020 Sep 2;11:1911. doi: 10.3389/fimmu.2020.01911. eCollection 2020.

引用本文的文献

1
Glycoproteomics analysis of complement factor H and its complement-regulatory function during -associated hemolytic uremic syndrome.
Front Immunol. 2025 Aug 21;16:1645196. doi: 10.3389/fimmu.2025.1645196. eCollection 2025.
3
The Role of von Willebrand Factor in the Pathogenesis of C3 Glomerulopathy.
Kidney Int Rep. 2025 Apr 3;10(6):1929-1938. doi: 10.1016/j.ekir.2025.03.058. eCollection 2025 Jun.
4
Altered metabolomics and inflammatory transcriptomics in human bone marrow adipocytes after acute high calorie diet and acute fasting.
Front Endocrinol (Lausanne). 2025 Jun 16;16:1591280. doi: 10.3389/fendo.2025.1591280. eCollection 2025.
6
Expression of innate immunity genes in human hematopoietic stem/progenitor cells - single cell RNA-seq analysis.
Front Immunol. 2025 Apr 8;16:1515856. doi: 10.3389/fimmu.2025.1515856. eCollection 2025.
7
Effective long-term treatment with moss-produced factor H by overcoming the antibody response in a mouse model of C3G.
Front Immunol. 2025 Mar 7;16:1535547. doi: 10.3389/fimmu.2025.1535547. eCollection 2025.
8
HTRA1 and complement activation in neovascular age-related macular degeneration.
Jpn J Ophthalmol. 2025 May;69(3):453-459. doi: 10.1007/s10384-024-01153-4. Epub 2025 Feb 12.
9
Tissue origin of endothelial cells determines immune system modulation and regulation of HIF-1α-, TGF-β-, and VEGF signaling.
iScience. 2025 Jan 2;28(2):111740. doi: 10.1016/j.isci.2024.111740. eCollection 2025 Feb 21.
10
Survival of Strain B31 in Human Serum Is Not Dependent on C4BP Binding to the Bacterial Surface.
Pathogens. 2024 Nov 8;13(11):976. doi: 10.3390/pathogens13110976.

本文引用的文献

1
An evaluation of the role of properdin in alternative pathway activation on Neisseria meningitidis and Neisseria gonorrhoeae.
J Immunol. 2010 Jul 1;185(1):507-16. doi: 10.4049/jimmunol.0903598. Epub 2010 Jun 7.
2
Native polymeric forms of properdin selectively bind to targets and promote activation of the alternative pathway of complement.
Immunobiology. 2010 Nov;215(11):932-40. doi: 10.1016/j.imbio.2010.02.002. Epub 2010 Feb 12.
3
Mesenchymal stem cells inhibit complement activation by secreting factor H.
Stem Cells Dev. 2010 Nov;19(11):1803-9. doi: 10.1089/scd.2009.0418. Epub 2010 Aug 1.
4
Review of meningococcal group B vaccines.
Clin Infect Dis. 2010 Mar 1;50 Suppl 2(S2):S54-65. doi: 10.1086/648966.
6
Annexin-II, DNA, and histones serve as factor H ligands on the surface of apoptotic cells.
J Biol Chem. 2010 Feb 5;285(6):3766-3776. doi: 10.1074/jbc.M109.045427. Epub 2009 Dec 1.
7
Properdin: emerging roles of a pattern-recognition molecule.
Annu Rev Immunol. 2010;28:131-55. doi: 10.1146/annurev-immunol-030409-101250.
8
Factor H in porcine seminal plasma protects sperm against complement attack in genital tracts.
J Biol Chem. 2010 Jan 15;285(3):2184-92. doi: 10.1074/jbc.M109.063495. Epub 2009 Nov 17.
9
Serum resistance of Acinetobacter baumannii through the binding of factor H to outer membrane proteins.
FEMS Microbiol Lett. 2009 Dec;301(2):224-31. doi: 10.1111/j.1574-6968.2009.01820.x. Epub 2009 Oct 13.
10
Severe atypical HUS caused by CFH S1191L--case presentation and review of treatment options.
Pediatr Nephrol. 2010 Jan;25(1):97-104. doi: 10.1007/s00467-009-1306-7. Epub 2009 Oct 24.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验